Structural dynamics of regulatory RNAs and ribonucleoproteins
调节RNA和核糖核蛋白的结构动力学
基本信息
- 批准号:10656556
- 负责人:
- 金额:$ 37.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-22 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAddressAdoptedArchitectureBindingBiochemistryBiological ModelsBiological ProcessBiologyCell physiologyComplexDiseaseDwarfismElementsGenetic DiseasesGenetic TranscriptionGenotoxic StressHIV-1HealthHeart DiseasesHumanKnowledgeLigandsMalignant NeoplasmsMass Spectrum AnalysisMolecularMolecular ConformationNMR SpectroscopyNormal CellPhosphotransferasesPolymersPositive Transcriptional Elongation Factor BProteinsProteomeRNARNA ConformationRNA FoldingRNA Polymerase IIRNA-Binding ProteinsRNA-Protein InteractionResearchResolutionRibonucleoproteinsRoleSpecificityStimulusStructureViralVirusWorkX-Ray Crystallographyaptamercofactorimprovedinsightinterdisciplinary approachmolecular assembly/self assemblymolecular recognitionprogramsprotein complexprotein protein interactionrational designresponsesmall moleculestructural biology
项目摘要
ABSTRACT
RNA is a structurally adaptive polymer that adopts complex tertiary structures and undergoes dramatic large-
scale conformational changes to regulate cellular activity. Integral to RNA function is its remarkable plasticity
and ability to structurally adapt in response to stimuli including small molecules and protein cofactors. Despite a
central role in biology, a comprehensive understanding of the principles that govern RNA folding and molecular
recognition is lacking. This research program addresses these gaps to understand, at an atomic level, how RNA
folds and recognizes binding partners during normal cell function and in disease states. Using RNA aptamers
and the 7SK ribonucleoprotein (RNP) as model systems, we combine solution NMR spectroscopy, X-ray
crystallography, mass spectrometry, and basic biochemistry in a multidisciplinary approach to advance
understanding of RNA structural dynamics and molecular assembly. The eukaryotic 7SK RNP is a major
regulator of transcription. Comprised of the 7SK RNA and protein components, 7SK RNP binds and inactivates
the kinase activity of the essential positive transcription elongation factor b (P-TEFb). P-TEFb must be released
from the 7SK RNP to activate RNA Polymerase II transcription processive elongation. P-TEFb dysregulation or
7SK RNP malfunction is associated with several genetic diseases including cancers, heart disease, and
primordial dwarfism. Moreover, several viruses manipulate host 7SK RNP for viral survival, notably HIV-1 and
more recently SARS-CoV-2 underscoring the significance of 7SK RNP in biological processes. Despite its critical
function and biomedical significance, there are presently few mechanistic insights into 7SK RNP function in stark
contrast to other regulatory RNPs. This gap is largely due to a lack of fundamental knowledge on basic 7SK RNP
features: how 7SK RNA folds, how proteins assemble onto 7SK RNA, and how 7SK RNP is structured. There is
a critical need to answer these outstanding questions to provide foundational insights into 7SK RNP structural
biology, and are essential to achieving a comprehensive understanding of 7SK RNP and its central role in
biology. Over the next five years, we will determine high resolution structures of RNA aptamer-ligand complexes,
7SK RNA elements involved in P-TEFb release, and 7SK RNA-protein complexes. We will identify the
determinants for RNA-ligand or RNA-protein binding specificity, elucidate 7SK RNA conformational dynamics,
and uncover the 7SK RNP proteome and protein-protein interaction network during normal cell function and
under genotoxic stress. Long-term, we will use newly gained knowledge to rationally design improved aptamer-
ligand pairs, determine global folding and dynamics of 7SK RNA, identify the molecular mechanisms of P-TEFb
release from 7SK RNP, and determine the 7SK RNP macromolecular architecture. Findings will address critical
knowledge gaps in RNA molecular recognition, 7SK RNA structure, 7SK RNA-protein recognition, and RNP
organization. This work will provide fundamental knowledge of RNA-protein interactions that can be extended to
understanding the foundational principles of RNA-protein recognition for other RNPs.
摘要
RNA是一种结构适应性聚合物,具有复杂的三级结构,并经历了巨大的-
缩放构象变化以调节细胞活性。RNA功能不可或缺的一点是其显著的可塑性
以及响应于包括小分子和蛋白质辅因子的刺激而结构适应的能力。尽管
在生物学中的核心作用,对RNA折叠和分子生物学原理的全面理解,
缺乏认可。这项研究计划解决了这些差距,以了解在原子水平上,RNA如何
在正常细胞功能和疾病状态下折叠并识别结合伴侣。使用RNA适体
和7SK核糖核蛋白(RNP)作为模型体系,我们结合联合收割机溶液核磁共振谱、X射线衍射、
晶体学、质谱学和基础生物化学的多学科方法,
理解RNA结构动力学和分子组装。真核生物7SK RNP是一种主要的
转录调节因子由7SK RNA和蛋白质组分组成,7SK RNP结合并灭活
必需正转录延伸因子B(P-TEF B)的激酶活性。必须释放P-TEFb
从7SK RNP激活RNA聚合酶II转录进行性延伸。P-TEFb失调或
7SK RNP功能障碍与几种遗传疾病有关,包括癌症、心脏病和糖尿病。
原始侏儒症此外,几种病毒操纵宿主7SK RNP用于病毒存活,特别是HIV-1和
最近SARS-CoV-2强调了7SK RNP在生物过程中的重要性。尽管其关键
功能和生物医学意义,目前很少有机制的见解7SK RNP功能在斯塔克
与其他监管RNP相比。这一差距很大程度上是由于缺乏基本7 SK RNP的基础知识
它的特点是:7SK RNA如何折叠,蛋白质如何组装到7SK RNA上,以及7SK RNP如何结构化。有
迫切需要回答这些悬而未决的问题,以提供对7SK RNP结构的基本见解
生物学,并且对于全面了解7SK RNP及其在以下方面的核心作用至关重要:
生物学在接下来的五年里,我们将确定RNA适体-配体复合物的高分辨率结构,
参与P-TEFb释放的7SK RNA元件和7SK RNA-蛋白质复合物。我们将确定
RNA-配体或RNA-蛋白质结合特异性的决定簇,阐明7SK RNA构象动力学,
揭示7SK RNP蛋白质组和蛋白质-蛋白质相互作用网络在正常细胞功能,
基因毒性压力下。从长远来看,我们将利用新获得的知识来合理设计改进的适体-
配体对,确定7SK RNA的整体折叠和动力学,确定P-TEFb的分子机制
从7SK RNP释放,并确定7SK RNP大分子结构。调查结果将解决关键问题
RNA分子识别、7SK RNA结构、7SK RNA-蛋白质识别和RNP方面的知识缺口
organization.这项工作将提供RNA-蛋白质相互作用的基础知识,可以扩展到
理解其他RNP的RNA-蛋白质识别的基本原理。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Eichhorn其他文献
Catherine Eichhorn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Eichhorn', 18)}}的其他基金
Structural dynamics of regulatory RNAs and ribonucleoproteins
调节RNA和核糖核蛋白的结构动力学
- 批准号:
10491733 - 财政年份:2021
- 资助金额:
$ 37.25万 - 项目类别:
Structural dynamics of regulatory RNAs and ribonucleoproteins
调节RNA和核糖核蛋白的结构动力学
- 批准号:
10276765 - 财政年份:2021
- 资助金额:
$ 37.25万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Research Grant














{{item.name}}会员




